Measurements of alanine aminotransf erase and aspartate aminotransferase with the SMAC were evaluated for correlation with the ABA-100, precision, linearity, and carryover. We assayed 200 specimens with normal and abnormal aminotransf erase activities with both the SMAC (y) and the ABA-100 (x 
following specimens with alanine aminotransferase activities >400 U/L and (or) aspartate aminotransferase activities >500 U/L should be re-analyzed.
A previous report (1) 
Measurement with the ABA-100
ALT and AST assays with the ABA-lOU (Abbott Laboratories, South Pasadena, CA 91030) are also based on the manual procedure developed by Henry et al. (4). The reagents ("A-Gent"; Abbott Laboratories), supplied lyophilized, were reconstituted with de-ionized water as directed in the procedural insert. Although use of a 1:51 dilution plate is recommended by the manufacturer, we found precision to be better at a lower dilution, and we used the 1:26 dilution plate for these ALT and AST assays. Here also measurements were made at 37 #{176}C and results are reported in international (IUB) units per liter (UIL).
Preparation of the Sample
All of the serum samples were from blood collected in evacuated collection tubes without anticoagulants. All sample dilutions were made with 0.15 mol/L NaC1.
Results and Discussion
Comparison of ALT and AST assays done with SMAC and ABA-100.
ALT and AST assays with the SMAC and the ABA-100 were compared by analyzing each of 200 specimens with both analyzers. The ABA-100 was selected for use in this comparison because of our excellent experience with the reagents and the acceptability of the rate measurement. were determined by assaying control pools (different from those used in assessing intra-assay precision) with low (LOW), normal (NOR), and elevated (ELE) activities during 31 days. The following data ware obtained: AST (LOW: I = 15.7 ± 2.3 U/L, CV = 14.6%; NOR: I = 28.1 ± 3.1 UfL, CV = 11.0%; ELE: I = 96.1 ± 6.3 U/L, CV = 6.6%); and ALT (LOW: I = 11.7 ± 3.0 UIL, CV = 25.6%; NOR: I = 29.6 ± 3.6 U/L, CV = 12.2%; ELE: I = 127.1 ± 6.1 U/L, CV = 4.8%). Both intra-and inter-assay variations with the SMAC were acceptable for both aminotransferases; the precision of AST measurement was better. In similar precision studies with the ABA-100, we obtained the following intra-assay precision data (n = Sample-to-sample interactions (carryovers) of the aminotransferases with the SMAC were determined according to the procedure outlined by Broughton et al. (11) . This protocol requires that a specimen with high enzyme activity be analyzed three times (H1, H2, H3) followed immediately by analysis of a specimen of low enzyme activity, which is also assayed three times (L1, L2, L3). The carryover or percent interaction (%I) is calculated as follows:
(L1 -L3)/(H3 -L3) X 100 = %I. Table 1 summarizes our carryover data for ALT and AST with the SMAC. The carryover of ALT is acceptable (%I <2.5) at enzyme activities less than about 350 U/L; however, all specimens assayed immediately after specimens with ALT activities greater than about 400 U/L should be re-assayed to verify the initial result. Our carryover data for AST, also presented in Table 1 , indicate that the carryover of AST is acceptable (%I <2.5) at AST activities less than about 460 U/L; however, all specimens that are assayed immediately after specimens with activities greater than about 500 U/L should be re-assayed to guarantee valid results. Additional data on sample-to-sample interaction of the aminotransferases is present in Table 2 . These data were collected during 27  1140  595  89  31  12  13  12  13  1225  400  83  34  3  13  8  10  1400  875  115  87  46  37  45  37  1575  975  107  37  42  27  39  26  1600  50  133  50  14  21  14  16  1725  1260  133  #{149} 56  11  15  14  17  2540  845 routine testing when 10 specimens that immediately followed specimens with high ALT and (or) AST activities were reassayed with the SMAC and the ABA-100. The data summarized in Table 2 support the acceptable correlation discussed above between the SMAC and ABA-100, and further highlight the extent of the carryover problem. The carryover characteristics of both enzymes were very similar.
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